Filing Details
- Accession Number:
- 0001638599-17-000116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-27 16:12:52
- Reporting Period:
- 2016-12-01
- Filing Date:
- 2017-01-27
- Accepted Time:
- 2017-01-27 16:12:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1429260 | Fortress Biotech Inc. | FBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 941841 | Md A Lindsay Rosenwald | C/O Fortress Biotech, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2016-12-01 | 731 | $2.03 | 5,304,470 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.001 | Acquisiton | 2017-01-01 | 552,698 | $0.00 | 5,857,168 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.001 | 170,983 | Indirect | By Capretti Grandi LLC |
| Common Stock, Par Value $0.001 | 453,822 | Indirect | By LAR Family Trusts |
| Common Stock, Par Value $0.001 | 742,861 | Indirect | By Paramount Biosciences |
| Common Stock, Par Value $0.001 | 100,000 | Indirect | By The Lindsay A. Rosenwald Rhode Island Irrevocable Trust U/T/A DTD 8-28-01 |
| Common Stock, Par Value $0.001 | 80,000 | Indirect | By The Lindsay A. Rosenwald Alaska Irrevocable Trust U/T/A DTD 8-29-01 |
| Common Stock, Par Value $0.001 | 720,000 | Indirect | By The Lindsay A. Rosenwald 2000 Irrevocable Trust U/T/A DTD 5-24-00 |
| Common Stock, Par Value $0.001 | 100,000 | Indirect | By The Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust U/T/A DTD 8-29-01 |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase Common Stock | $1.37 | 2020-10-05 | 25,000 | 25,000 | Direct | |
| Common Stock | Options to purchase Common Stock | $6.25 | 2022-02-10 | 15,000 | 15,000 | Direct | |
| Common Stock | Options to purchase Common Stock | $7.42 | 2023-02-07 | 15,000 | 15,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-10-05 | 25,000 | 25,000 | Direct |
| 2022-02-10 | 15,000 | 15,000 | Direct |
| 2023-02-07 | 15,000 | 15,000 | Direct |
Footnotes
- These shares were acquired under the Issuer's 2012 Employee Stock Purchase Plan.
- Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan.
- This option is fully vested.
- One-third of the shares vested on each of February 10, 2013, 2014 and 2015.
- One-third of the shares vested on each of February 7, 2014, 2015 and 2016.
Billionaire Hedge Funds
